[How I treat gastrointestinal tract acute graft versus host disease with fecal microbiota transplantation].
作者信息
Tang X W, Wu D P
机构信息
Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Collaborative Innovation Center of Hematology, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2022 May 14;43(5):365-369. doi: 10.3760/cma.j.issn.0253-2727.2022.05.003.
Abstract
摘要
相似文献
1
[How I treat gastrointestinal tract acute graft versus host disease with fecal microbiota transplantation].[我如何通过粪便微生物群移植治疗胃肠道急性移植物抗宿主病]
Zhonghua Xue Ye Xue Za Zhi. 2022 May 14;43(5):365-369. doi: 10.3760/cma.j.issn.0253-2727.2022.05.003.
2
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft--host-disease.反复进行粪便微生物群移植可减轻急性难治性胃肠道移植物抗宿主病中的腹泻，并导致粪便微生物群的持续变化。
Haematologica. 2017 May;102(5):e210-e213. doi: 10.3324/haematol.2016.154351. Epub 2017 Feb 2.
3
Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study.粪菌移植治疗激素耐药性肠道急性移植物抗宿主病：一项初步研究。
Front Immunol. 2018 Sep 25;9:2195. doi: 10.3389/fimmu.2018.02195. eCollection 2018.
4
Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.粪便微生物群移植治疗肠道类固醇耐药移植物抗宿主病：两例病例报告及文献复习。
J Int Med Res. 2020 Jun;48(6):300060520925693. doi: 10.1177/0300060520925693.
5
Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report.使用无关供体粪便微生物群移植胶囊治疗肠道移植物抗宿主病：一例报告。
Medicine (Baltimore). 2020 Sep 18;99(38):e22129. doi: 10.1097/MD.0000000000022129.
6
Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation.粪便微生物移植：异基因造血细胞移植后恢复受损的微生物组。
Biol Blood Marrow Transplant. 2019 Jan;25(1):e17-e22. doi: 10.1016/j.bbmt.2018.10.022. Epub 2018 Nov 5.
7
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient.粪便微生物群移植治疗一名儿科患者的类固醇难治性肠道移植物抗宿主病
Bone Marrow Transplant. 2022 Oct;57(10):1600-1603. doi: 10.1038/s41409-022-01752-0. Epub 2022 Jul 14.
8
Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.粪便微生物群移植用于肠道类固醇难治性急性移植物抗宿主病患者。
Blood. 2016 Oct 20;128(16):2083-2088. doi: 10.1182/blood-2016-05-717652. Epub 2016 Jul 26.
9
[Fecal microbiota transplantation for patients with refractory diarrhea after allogeneic hematopoietic stem cell transplantation].异基因造血干细胞移植后难治性腹泻患者的粪便微生物群移植
Zhonghua Xue Ye Xue Za Zhi. 2019 Oct 14;40(10):853-855. doi: 10.3760/cma.j.issn.0253-2727.2019.10.011.
10
[Fecal microbiota transplantation for acute graft-versus-host disease of the gut].[粪便微生物群移植治疗肠道急性移植物抗宿主病]
Rinsho Ketsueki. 2017;58(5):499-505. doi: 10.11406/rinketsu.58.499.
本文引用的文献
1
Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.粪便微生物移植治疗 IV 级激素难治性胃肠道移植物抗宿主病患者的安全性和有效性：FMT2017002 试验的中期结果。
Front Immunol. 2021 Jun 17;12:678476. doi: 10.3389/fimmu.2021.678476. eCollection 2021.
2
Advances in Intestinal Barrier Preservation and Restoration in the Allogeneic Hematopoietic Cell Transplantation Setting.异基因造血细胞移植中肠道屏障保护与修复的进展
J Clin Med. 2021 Jun 6;10(11):2508. doi: 10.3390/jcm10112508.
3
Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020.系统评价：2000 年至 2020 年粪便微生物群移植相关不良事件的全球发生率。
Aliment Pharmacol Ther. 2021 Jan;53(1):33-42. doi: 10.1111/apt.16148. Epub 2020 Nov 7.
4
Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients.供体粪便微生物群移植可改善异基因造血细胞移植受者的肠道移植物抗宿主病。
Sci Transl Med. 2020 Aug 12;12(556). doi: 10.1126/scitranslmed.aaz8926.
5
Nanjing consensus on methodology of washed microbiota transplantation.《南京粪菌移植技术方法学共识》
Chin Med J (Engl). 2020 Oct 5;133(19):2330-2332. doi: 10.1097/CM9.0000000000000954.
6
Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity.肠道微生物群的功能和系统发育改变与移植物抗宿主病的严重程度相关。
Blood Adv. 2020 May 12;4(9):1824-1832. doi: 10.1182/bloodadvances.2020001531.
7
Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening.经洗涤的微生物群移植与手动粪便微生物群移植：临床发现、动物研究和体外筛选。
Protein Cell. 2020 Apr;11(4):251-266. doi: 10.1007/s13238-019-00684-8. Epub 2020 Jan 9.
8
Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后类固醇难治性移植物抗宿主病的结果、危险因素和治疗的回顾性单中心分析。
Bone Marrow Transplant. 2019 Nov;54(11):1805-1814. doi: 10.1038/s41409-019-0544-y. Epub 2019 May 14.
9
Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease.采用冷冻胶囊进行粪便微生物群移植治疗难治性急性肠道移植物抗宿主病。
Blood Adv. 2018 Nov 27;2(22):3097-3101. doi: 10.1182/bloodadvances.2018024968.
10
Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study.粪菌移植治疗激素耐药性肠道急性移植物抗宿主病：一项初步研究。
Front Immunol. 2018 Sep 25;9:2195. doi: 10.3389/fimmu.2018.02195. eCollection 2018.
Zotero 插件